HIV Impairs Opsonic Phagocytic Clearance of Pregnancy-associated Malaria Parasites
Overview
Authors
Affiliations
Background: Primigravid (PG) women are at risk for pregnancy-associated malaria (PAM). Multigravid (MG) women acquire protection against PAM; however, HIV infection impairs this protective response. Protection against PAM is associated with the production of IgG specific for variant surface antigens (VSA-PAM) expressed by chondroitin sulfate A (CSA)-adhering parasitized erythrocytes (PEs). We hypothesized that VSA-PAM-specific IgG confers protection by promoting opsonic phagocytosis of PAM isolates and that HIV infection impairs this response.
Methods And Findings: We assessed the ability of VSA-PAM-specific IgG to promote opsonic phagocytosis of CSA-adhering PEs and the impact of HIV infection on this process. Opsonic phagocytosis assays were performed using the CSA-adherent parasite line CS2 and human and murine macrophages. CS2 PEs were opsonized with plasma or purified IgG subclasses from HIV-negative or HIV-infected PG and MG Kenyan women or sympatric men. Levels of IgG subclasses specific for VSA-PAM were compared in HIV-negative and HIV-infected women by flow cytometry. Plasma from HIV-negative MG women, but not PG women or men, promoted the opsonic phagocytosis of CSA-binding PEs (p < 0.001). This function depended on VSA-PAM-specific plasma IgG1 and IgG3. HIV-infected MG women had significantly lower plasma opsonizing activity (median phagocytic index 46 [interquartile range (IQR) 18-195] versus 251 [IQR 93-397], p = 0.006) and levels of VSA-PAM-specific IgG1 (mean fluorescence intensity [MFI] 13 [IQR 11-20] versus 30 [IQR 23-41], p < 0.001) and IgG3 (MFI 17 [IQR 14-23] versus 28 [IQR 23-37], p < 0.001) than their HIV-negative MG counterparts.
Conclusions: Opsonic phagocytosis may represent a novel correlate of protection against PAM. HIV infection may increase the susceptibility of multigravid women to PAM by impairing this clearance mechanism.
Impact of Infections During Pregnancy on Transplacental Antibody Transfer.
Coler C, King-Nakaoka E, Every E, Chima S, Vong A, Del Rosario B Vaccines (Basel). 2024; 12(10.
PMID: 39460363 PMC: 11512415. DOI: 10.3390/vaccines12101199.
Raghavan S, Dagil R, Lopez-Perez M, Conrad J, Bassi M, Del Pilar Quintana M PLoS Pathog. 2022; 18(11):e1010924.
PMID: 36383559 PMC: 9668162. DOI: 10.1371/journal.ppat.1010924.
Doritchamou J, Renn J, Jenkins B, Mahamar A, Dicko A, Fried M Elife. 2022; 11.
PMID: 35103596 PMC: 8959597. DOI: 10.7554/eLife.76264.
Can complement fix placental malaria?.
Doritchamou J, Duffy P BMC Med. 2021; 19(1):231.
PMID: 34503499 PMC: 8431923. DOI: 10.1186/s12916-021-02083-5.
Opi D, Boyle M, McLean A, Reiling L, Chan J, Stanisic D BMC Med. 2021; 19(1):201.
PMID: 34425801 PMC: 8383393. DOI: 10.1186/s12916-021-02061-x.